SCHEMBL4424650

SCHEMBL4424650

OCCNCc1ccc(-c2ccc(Cl)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 1/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ CHRM2 P08172 1/20 0.58
▸ PDCD1 Q15116 1/20 0.56
▸ CD274 Q9NZQ7 1/20 0.56
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ HRH4 Q9H3N8 1/20 0.47
▸ HRH3 Q9Y5N1 1/20 0.47
▸ STAT3 P40763 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.46
▸ TMEM97 Q5BJF2 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263025 0.94 CHRM2 (0.64) MCHR1SMN1; SMN2CHRM2PDCD1CD274
Hydrochloric Acid SCHEMBL948529 0.92 CHRM2 (0.62) MCHR1SMN1; SMN2CHRM2PDCD1CD274
SCHEMBL4551985 0.83 MCHR1 (0.51) MCHR1SMN1; SMN2CHRM2PDCD1CD274
SCHEMBL1625535 0.83 SMN1; SMN2 (0.64) MCHR1SMN1; SMN2CHRM2PDCD1CD274
SCHEMBL6163688 0.82 CHRM2 (0.71) MCHR1SMN1; SMN2CHRM2KMT2AMEN1
SCHEMBL12298701 0.82 SMN1; SMN2 (0.89) MCHR1SMN1; SMN2CHRM2PDCD1CD274
SCHEMBL11094422 0.81 CHRM2 (0.75) SMN1; SMN2CHRM2KMT2AMEN1LMNA
SCHEMBL14420382 0.81 SMN1; SMN2 (0.68) MCHR1SMN1; SMN2CHRM2LMNAALDH1A1
SCHEMBL4424618 0.81 CD274 (0.54) MCHR1SMN1; SMN2CHRM2PDCD1CD274
SCHEMBL4423111 0.78 USP2 (0.51) MCHR1SMN1; SMN2CHRM2PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1479671-B1 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2009-05-27 — — EP disclosed
US-7115616-B2 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2006-10-03 — — US disclosed
US-6953803-B1 1-[(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)]-2-(4-fluorobenzyl)thio-5-(1-methyl-4-pyrazolylmethyl)pyrimidin-4-one; enzyme inhibitors of lipoprotein associated phospholipase A2 (Lp-PLA2); atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2005-10-11 — — US disclosed
EP-1175408-A1 PYRIMIDINONE COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 2002-01-30 — — EP disclosed
WO-2000066567-A1 PYRIMIDINONE COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 2000-11-09 — — WO disclosed
Send feedback